Rhythm Biosciences (FRA:0RY) ROE % Adjusted to Book Value : -8.75% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Rhythm Biosciences ROE % Adjusted to Book Value?

Rhythm Biosciences's ROE % for the quarter that ended in Dec. 2023 was -228.17%. Rhythm Biosciences's PB Ratio for the quarter that ended in Dec. 2023 was 26.09. Rhythm Biosciences's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -8.75%.

Rhythm Biosciences ROE % Adjusted to Book Value Historical Data

The historical data trend for Rhythm Biosciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences ROE % Adjusted to Book Value Chart

Rhythm Biosciences Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-8.10

Rhythm Biosciences Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial								-	-	-	-8.27	-8.75

Competitive Comparison of Rhythm Biosciences's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Rhythm Biosciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhythm Biosciences's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rhythm Biosciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Rhythm Biosciences's ROE % Adjusted to Book Value falls into.

Rhythm Biosciences ROE % Adjusted to Book Value Calculation

Rhythm Biosciences's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-119.23%	/	14.72
	=	-8.10%

Rhythm Biosciences's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-228.17%	/	26.09
	=	-8.75%

Rhythm Biosciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Biosciences (FRA:0RY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (FRA:0RY) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

RHY:Australia

Address

30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010

Website

https://www.rhythmbio.com

Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.

Rhythm Biosciences (FRA:0RY) Headlines

No Headlines